Unmasking of incipient amyotrophic lateral sclerosis by botulinum toxin therapy.

Unmasking of incipient amyotrophic lateral sclerosis by botulinum toxin therapy.

Pokaż inne wersje (1)

Opis bibliograficzny
Główni autorzy:	Kent, L, Davies, P, Kennett, R, Wimalaratna, S, Kerr, R, Turner, M, Talbot, K
Format:	Journal article
Język:	English
Wydane:	2013

Podobne zapisy

Unmasking of incipient amyotrophic lateral sclerosis by botulinum toxin therapy
od: Kent, L, i wsp.
Wydane: (2013)

Botulinum Toxin Type A and Physiotherapy in Spasticity of the Lower Limbs Due to Amyotrophic Lateral Sclerosis
od: Riccardo Marvulli, i wsp.
Wydane: (2019-07-01)

Application of botulinum toxin to treat sialorrhea in amyotrophic lateral sclerosis patients: a literature review
od: Ademar Francisco de Oliveira Filho, i wsp.

Biomarkers in amyotrophic lateral sclerosis.
od: Turner, M, i wsp.
Wydane: (2009)

Sweet food preference in amyotrophic lateral sclerosis
od: Turner, M, i wsp.
Wydane: (2017)

Psychiatric disorders prior to amyotrophic lateral sclerosis
od: Turner, M, i wsp.
Wydane: (2016)

Myelin imaging in amyotrophic and primary lateral sclerosis.
od: Kolind, S, i wsp.
Wydane: (2013)

Motor system biomarkers in amyotrophic lateral sclerosis
od: Edmond, EC, i wsp.
Wydane: (2019)

Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study.
od: Turner, M, i wsp.
Wydane: (2013)

Quantitative FLAIR MRI in amyotrophic lateral sclerosis
od: Fabes, J, i wsp.
Wydane: (2017)

CSF chitinase proteins in amyotrophic lateral sclerosis
od: Thompson, A, i wsp.
Wydane: (2019)

The reunification of amyotrophic lateral sclerosis
od: Turner, M
Wydane: (2018)

Progressive hemiparesis (Mills syndrome) with aphasia in amyotrophic lateral sclerosis.
od: Bäumer, D, i wsp.
Wydane: (2014)

Genetics of sporadic amyotrophic lateral sclerosis.
od: Schymick, J, i wsp.
Wydane: (2007)

Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model.
od: Turner, B, i wsp.
Wydane: (2009)

Amyotrophic lateral sclerosis: the complex path to precision medicine
od: Talbot, K, i wsp.
Wydane: (2018)

Amyotrophic lateral sclerosis.
od: Kiernan, M, i wsp.
Wydane: (2011)

Oculomotor dysfunction in amyotrophic lateral sclerosis: a comprehensive review.
od: Sharma, R, i wsp.
Wydane: (2011)

The Basis of Cognitive and Behavioral Dysfunction in Amyotrophic Lateral Sclerosis
od: Alexander Bampton, i wsp.
Wydane: (2024-11-01)

The diagnostic pathway and prognosis in bulbar-onset amyotrophic lateral sclerosis.
od: Turner, M, i wsp.
Wydane: (2010)

A case of celiac disease mimicking amyotrophic lateral sclerosis.
od: Turner, M, i wsp.
Wydane: (2007)

Imaging Cerebral Activity in Amyotrophic Lateral Sclerosis
od: Malcolm Proudfoot, i wsp.
Wydane: (2019-01-01)

The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis
od: Menke, R, i wsp.
Wydane: (2017)

The tough body at the epicentre of amyotrophic lateral sclerosis
od: Turner, M, i wsp.
Wydane: (2017)

Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis
od: Thompson, A, i wsp.
Wydane: (2018)

Neuroimaging endpoints in amyotrophic lateral sclerosis
od: Menke, R, i wsp.
Wydane: (2016)

Amyotrophic lateral sclerosis: Cell vulnerability or system vulnerability?
od: Talbot, K
Wydane: (2014)

Amyotrophic lateral sclerosis: cell vulnerability or system vulnerability?
od: Talbot, K
Wydane: (2014)

Defective cholesterol metabolism in amyotrophic lateral sclerosis
od: Jonas Abdel-Khalik, i wsp.
Wydane: (2017-01-01)

Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model
od: Bradley J. Turner, i wsp.
Wydane: (2009-06-01)

Neuroimaging in amyotrophic lateral sclerosis.
od: Turner, M, i wsp.
Wydane: (2012)

Gene Therapy in Amyotrophic Lateral Sclerosis
od: Ton Fang, i wsp.
Wydane: (2022-06-01)

Gene therapy for amyotrophic lateral sclerosis
od: Thais Federici, i wsp.
Wydane: (2012-11-01)

Controversies and priorities in amyotrophic lateral sclerosis.
od: Turner, M, i wsp.
Wydane: (2013)

The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis.
od: Gray, E, i wsp.
Wydane: (2015)

The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis
od: R.A.L. Menke, i wsp.
Wydane: (2018-01-01)

Untangling neuroinflammation in amyotrophic lateral sclerosis
od: Thompson, AG, i wsp.
Wydane: (2019)

Defective cholesterol metabolism in amyotrophic lateral sclerosis.
od: Abdel-Khalik, J, i wsp.
Wydane: (2016)

Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations.
od: Bowser, R, i wsp.
Wydane: (2011)

Regional callosal integrity and bilaterality of limb weakness in amyotrophic lateral sclerosis
od: Tu, S, i wsp.
Wydane: (2020)